News
Stocks were up this week as the summer rally continues. There was mixed news from the tech sector this week, but on the whole ...
Neuralink, Elon Musk’s brain chip company, has partnered with researchers in Spain and California on a new clinical trial for what’s being called a “Smart ...
If you collect the data today, what can you read from it five years from now because the technology is advancing so quickly?” ...
To meet the requirements for FDA Breakthrough Device Designation, CDx Diagnostics submitted technical and clinical evidence ...
Most Americans encounter the Federal Trade Commission only if they’ve been scammed: It handles identity theft, fraud, and ...
In addition to telling time, smartwatches can track your steps, heart rate, blood pressure and sleeping patterns. Now, a ...
Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...
The earnings release highlighted strong GAAP revenue growth that beat consensus estimates, adjusted earnings per share (non-GAAP) that outpaced expectations, and an increase in adjusted operating ...
Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated ...
But according to three current FDA employees “ELSA” is creating studies that don’t exist. They say that makes it hard to ...
It's unclear whether the errors were generated by artificial intelligence. But the mistakes brought to mind the criticism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results